These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29409706)

  • 1. Blocking Ras inhibition as an antitumor strategy.
    Marín-Ramos NI; Ortega-Gutiérrez S; López-Rodríguez ML
    Semin Cancer Biol; 2019 Feb; 54():91-100. PubMed ID: 29409706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct inhibition of RAS: Quest for the Holy Grail?
    Spencer-Smith R; O'Bryan JP
    Semin Cancer Biol; 2019 Feb; 54():138-148. PubMed ID: 29248537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-Ras protein as a drug target.
    McCormick F
    J Mol Med (Berl); 2016 Mar; 94(3):253-8. PubMed ID: 26960760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
    Sacco E; Spinelli M; Vanoni M
    Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioblockades join the assault on small G protein signalling.
    Mott HR; Owen D
    Semin Cancer Biol; 2019 Feb; 54():149-161. PubMed ID: 29307570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of RAS: New hope for drugging the "undruggable".
    Khan I; Rhett JM; O'Bryan JP
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118570. PubMed ID: 31678118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RAS: proven and potential vulnerabilities.
    Zuberi M; Khan I; O'Bryan JP
    Biochem Soc Trans; 2020 Oct; 48(5):1831-1841. PubMed ID: 32869838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Approaches to RAS Mutation.
    Scott AJ; Lieu CH; Messersmith WA
    Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology, pathology, and therapeutic targeting of RAS.
    Rhett JM; Khan I; O'Bryan JP
    Adv Cancer Res; 2020; 148():69-146. PubMed ID: 32723567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras proteins as therapeutic targets.
    Chakraborty A; Linnane E; Ross S
    Biochem Soc Trans; 2018 Oct; 46(5):1303-1311. PubMed ID: 30154091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Ras therapeutics in pancreatic cancer.
    Choi M; Bien H; Mofunanya A; Powers S
    Semin Cancer Biol; 2019 Feb; 54():101-108. PubMed ID: 29170065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endeavours in RAS Inhibition - the Past, Present, and Future.
    Hussain J; Kirubakaran S; Ravi S
    Curr Top Med Chem; 2020; 20(29):2708-2722. PubMed ID: 32885752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Ras palmitoylation/depalmitoylation cycle in cancer.
    Lin DTS; Davis NG; Conibear E
    Biochem Soc Trans; 2017 Aug; 45(4):913-921. PubMed ID: 28630138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.
    Lu S; Jang H; Gu S; Zhang J; Nussinov R
    Chem Soc Rev; 2016 Sep; 45(18):4929-52. PubMed ID: 27396271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the RAS-dependent chemoresistance: The Warburg connection.
    Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
    Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.
    Asati V; Mahapatra DK; Bharti SK
    Eur J Med Chem; 2017 Jan; 125():299-314. PubMed ID: 27688185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective.
    Sautier B; Nising CF; Wortmann L
    Angew Chem Int Ed Engl; 2016 Dec; 55(52):15982-15988. PubMed ID: 27635522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Prospects for Targeting RAS.
    Singh H; Longo DL; Chabner BA
    J Clin Oncol; 2015 Nov; 33(31):3650-9. PubMed ID: 26371146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.
    Michael JV; Goldfinger LE
    Semin Cancer Biol; 2019 Feb; 54():121-130. PubMed ID: 29203271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.